Back to search
Autosomal Recessive Congenital Ichthyosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autosomal Recessive Congenital Ichthyosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Autosomal Recessive Congenital Ichthyosis trials you may qualify forAutosomal recessive congenital ichthyoses (ARCI) are monogenic diseases of cornification that correspond to a diffuse abnormality (affecting the entire integume…
The goal of this study is to identify important biological pathways involved in a variety of ichtyosis, using transcriptomic and proteomic techniques, with the…
This is a phase 2 randomized, multi-center, double-blind, vehicle controlled, 90 day, safety, efficacy, and systemic exposure study followed by a 90 day open-la…
KB105-02 is an intrasubject randomized, placebo-controlled, double-blind study to evaluate the safety and efficacy of KB105 in children and adults with autosoma…
This study is an intra-patient comparison of KB105 and placebo-administered Target Areas. The primary objectives of this study are to evaluate safety and Invest…
The ichthyoses are a group of lifelong genetic disorders which share characteristics of generalized skin thickening, scaling and underlying cutaneous inflammati…
This is an experimental non-randomized clinical study aimed at expanding the indications for the use of biological drugs with the aim of using them for the path…